Composition formula containing psoralen for inducing embryonic fibroblasts to directly reprogram into cardiomyocyte-like cells and induction method thereof

By contacting mouse embryonic fibroblasts with psoralen and forskolin, it is induced to reprogram into cardiomyocytes, which solves the problem of low cardiomyocyte production efficiency and significantly improves the induction efficiency of cardiomyocytes. Effect.

CN118773129BActive Publication Date: 2024-11-19INST OF BASIC THEORY OF TCM CHINA ACADEMY OF CHINESE MEDICAL SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411267826.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-11
Publication Date
2024-11-19
Estimated Expiration
2044-09-11

AI Technical Summary

Technical Problem

The non-regenerability of cardiomyocytes leads to challenges in the treatment of heart disease. The existing methods of inducing cardiomyocyte production are inefficient and difficult to meet clinical needs.

Method used

Using a composition containing psoralen, 2-[3-(6-methyl-2-pyridyl)-1H-pyrazole-4-yl]-1,5-naphthalidine and forskolin, by Mouse embryonic fibroblasts contacted, inducing their reprogramming into cardiomyocytes, improving the production efficiency of cardiomyocytes.

Benefits of technology

Spontaneously beating cells were induced within 8 hours to 4 days, increasing the number of cTnT and α-actinin-positive cells, and increasing the mRNA expression levels of RyR2, Tnnt2, Myh6, and β-MHC, significantly improving the induction efficiency of myocardial-like cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118773129B_ABST
    Figure CN118773129B_ABST
Patent Text Reader

Abstract

This invention belongs to the field of regenerative medicine, specifically relating to a composition formulation containing psoralen for the direct reprogramming of embryonic fibroblasts into cardiomyocyte-like cells and its induction method. The compound formulation includes psoralen, RepSox, and Forskolin. The combined application of psoralen with the small molecule compounds RepSox and Forskolin provided by this invention can significantly improve the efficiency of direct reprogramming of mouse embryonic fibroblasts into cardiomyocyte-like cells. This invention makes the industrial production of cardiomyocyte-like cells possible and has significant application value for research on heart diseases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of regenerative medicine, and specifically relates to a composition formula containing psoralen for inducing embryonic fibroblasts to directly reprogram into cardiomyocyte-like cells and an induction method thereof. Background Art

[0002] Cardiomyocytes, also known as myocardial fibers, are the basic cells that make up heart tissue and play a vital role in maintaining the normal function of the heart. Cardiomyocytes are one of the few non-renewable cells in the human body. The non-renewability of cardiomyocytes means that once cardiomyocytes are damaged or die, they cannot repair themselves or regenerate through cell division like other types of cells. This is a unique characteristic of cardiomyocytes and an important challenge in the treatment of heart disease.

[0003] Cardiomyocytes are the power source of the heart's pumping blood. They promote blood circulation through effective contraction and relaxation. Understanding the morphology, structure and functional characteristics of cardiomyocytes is the basis for a deep understanding of the heart's pumping mechanism. This special structure and function of cardiomyocytes enables them to work together to ensure that the heart can pump blood continuously and regularly, providing the necessary oxygen and nutrients to all tissues and organs in the body. Many heart diseases, such as myocardial infarction, coronary heart disease, myocarditis, heart failure, etc., are closely related to the damage, death or dysfunction of cardiomyocytes. By studying the changes in cardiomyocytes in disease states, the pathogenesis of these heart diseases can be revealed. For example, myocardial infarction is caused by severe ischemia, hypoxia and necrosis of cardiomyocytes due to coronary artery occlusion; heart failure is caused by a variety of reasons that cause weakened contractility of cardiomyocytes or reduced ventricular compliance, resulting in a decrease in the heart's pumping function.

[0004] As an important subject of cardiovascular disease research, the research results of cardiomyocytes not only help to reveal the pathogenesis and therapeutic targets of heart disease, but also promote the progress of the entire cardiovascular disease research field. For example, by constructing a cardiovascular disease model based on cardiomyocytes, the occurrence and development of the disease can be simulated, providing an important platform for drug screening and efficacy evaluation. In addition, the study of the electrophysiological characteristics of cardiomyocytes also provides new perspectives and methods for the diagnosis and treatment of cardiac electrophysiological diseases such as arrhythmias.

[0005] In summary, inducing cardiomyocyte generation is of great significance in promoting cardiac regeneration and repair, advancing research progress on cardiovascular diseases, and promoting drug development and clinical applications. However, the cell sources for inducing cardiomyocyte generation are limited. Even with appropriate cell sources and induction methods, the differentiation efficiency of cardiomyocytes is often low, which is difficult to meet clinical needs. Therefore, there is an urgent need to provide a method for inducing cardiomyocyte generation with high efficiency, which can be used to study the heart's pumping mechanism, reveal the pathogenesis of heart disease, guide the diagnosis and treatment of heart disease, promote research progress on cardiovascular diseases, and promote the development of personalized medicine. Summary of the invention

[0006] In order to solve the above problems, the present invention provides a composition containing psoralen that can effectively improve the efficiency of directly reprogramming mouse embryonic fibroblasts (MEFs) into induced cardiomyocytes (iCMs).

[0007] In one aspect, the present invention provides a composition for inducing the preparation of iCMs, comprising psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin.

[0008] Specifically, the concentrations of psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin can be 1µmol / L-100µmol / L, 1µmol / L-10µmol / L, and 1µmol / L-10µmol / L, respectively.

[0009] In some embodiments, the concentrations of psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin can be 10µmol / L, 5µmol / L and 10µmol / L, respectively.

[0010] In other embodiments, the concentrations of psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin can be 1 µmol / L, 10 µmol / L and 10 µmol / L, respectively.

[0011] In some other embodiments, the concentrations of psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin can be 100 µmol / L, 1 µmol / L and 1 µmol / L, respectively.

[0012] Specifically, the composition is added to the basal culture medium.

[0013] More specifically, the basic culture medium includes but is not limited to at least one of DMEM / F12, IMDM, M-199, RPMI-1640, MEM or DMEM.

[0014] Preferably, the basal culture medium may be high-glucose DMEM.

[0015] Specifically, the basic culture medium further includes at least one of fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS or non-essential amino acids.

[0016] Preferably, the basal culture medium further comprises fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS and non-essential amino acids.

[0017] In another aspect, the present invention provides a method for inducing preparation of cardiomyocyte-like cells, the method comprising the following steps: contacting fibroblasts with a composition to induce cell reprogramming of the fibroblasts to generate cardiomyocyte-like cells.

[0018] Specifically, the composition includes psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin.

[0019] More specifically, the concentrations of psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin can be 1µmol / L-100µmol / L, 1µmol / L-10µmol / L, and 1µmol / L-10µmol / L, respectively.

[0020] More specifically, the composition is added to a basal culture medium.

[0021] Preferably, the basic culture medium includes, but is not limited to, at least one of DMEM / F12, IMDM, M-199, RPMI-1640, MEM or DMEM.

[0022] Further preferably, the basal culture medium may be high-glucose DMEM.

[0023] More specifically, the basic culture medium also includes at least one of fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS or non-essential amino acids.

[0024] Preferably, the basal culture medium further comprises fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS and non-essential amino acids.

[0025] Further preferably, the concentrations of fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS and non-essential amino acids are: 5%-15% v / v, 0.5%-2% v / v, 30-70 mg / L, 0.05-0.2 mM, 1x-5x, 1x-5x.

[0026] Preferably, the concentrations of fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS and non-essential amino acids are: 5%-10% v / v, 1%-2% v / v, 30-50 mg / L, 0.1-0.2 mM, 1x-2x, 1x-2x.

[0027] Further preferably, the concentrations of fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS and non-essential amino acids are: 10% v / v, 1% v / v, 50 mg / L, 0.1 mM, 1x, 1x.

[0028] Specifically, the fibroblasts are derived from mouse embryos.

[0029] More specifically, the fibroblasts are derived from 10-15 day old mouse embryos.

[0030] Preferably, the fibroblasts are derived from 12-14 day old mouse embryos.

[0031] Further preferably, the fibroblasts are derived from 13.5-day-old mouse embryos.

[0032] In yet another aspect, the present invention provides cardiomyocytes prepared by induction of the aforementioned composition or method.

[0033] In yet another aspect, the present invention provides use of the aforementioned composition or method in preparing cardiomyocytes.

[0034] In another aspect, the present invention provides a kit, comprising the aforementioned composition and at least one basic culture medium

[0035] Specifically, the basic culture medium includes but is not limited to at least one of DMEM / F12, IMDM, M-199, RPMI-1640, MEM or DMEM.

[0036] Preferably, the basal culture medium may be high-glucose DMEM.

[0037] More specifically, the basic culture medium further includes at least one of fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS or non-essential amino acids.

[0038] Preferably, the basal culture medium further comprises fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS and non-essential amino acids.

[0039] Specifically, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine can be replaced with other TGF-β inhibitors.

[0040] Specifically, psoralen may be replaced by isopsoralen.

[0041] In the present invention, 2-[3-(6-methyl-2-pyridyl)-1H-pyrazol-4-yl]-1,5-naphthyridine is RepSox (R); forskolin is Forskolin (F); and psoralen is Psoralen (P).

[0042] The technical effects achieved by the present invention are:

[0043] (1) Adding psoralen to RepSox+Forskolin can induce spontaneous beating cells within 8h-4d.

[0044] (2) Adding psoralen to RepSox+Forskolin can induce more cTnT-positive cells.

[0045] (3) Adding psoralen to RepSox+Forskolin can induce more α-actinin-positive cells.

[0046] (4) Psoralen was added to RepSox+Forskolin to increase the expression levels of cellular RyR2, Tnnt2, Myh6, and β-MHC mRNA. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 The cell morphology changes after 4 days of induction in Example 1, where A is the P3 generation MEFs in normal culture; B is the CM group; C is the RF group; and D is the PRF group.

[0048] Figure 2 The expression levels of myocardial-related genes in each group after 4 days of induction in Example 1 are shown in Figure 1, where A is the expression level of TNNT2 mRNA; B is the expression level of MYH6 mRNA; C is the expression level of β-MHC mRNA; and D is the expression level of RyR2 mRNA.

[0049] Figure 3 The expression of myocardial-related protein CTNT in each group at 2 days after induction in Example 1.

[0050] Figure 4 The expression intensity changes of myocardial-related protein CTNT in each group at 2 days after induction in Example 1.

[0051] Figure 5 The expression of myocardial-related protein α-actinin in each group at 2 days after induction in Example 1.

[0052] Figure 6 The expression intensity changes of myocardial-related protein α-actinin in each group at 2 days after induction in Example 1.

[0053] Figure 7 The expression levels of myocardial-related genes in each group after 4 days of induction in Example 2 are shown in Figure 2, where A is the expression level of MYH6 mRNA; B is the expression level of TNNT2 mRNA; C is the expression level of β-MHC mRNA; and D is the expression level of RyR2 mRNA.

[0054] Figure 8 The expression levels of myocardial-related genes in each group after 4 days of induction in Example 3 are shown in Figure 3, where A is the expression level of TNNT2 mRNA; B is the expression level of MYH6 mRNA; C is the expression level of β-MHC mRNA; and D is the expression level of RyR2 mRNA.

[0055] Fig. 9 It is the TNNT2 and RyR2 mRNA expression levels of the CM group of Example 1, the PRF group of Example 1, the comparative example 1 and the comparative example 2; wherein A is the RyR2 mRNA expression level; and B is the TNNT2 mRNA expression level. DETAILED DESCRIPTION

[0056] The present invention will be further described in detail below in conjunction with specific examples. The following examples are not intended to limit the present invention, but are only intended to illustrate the present invention. The experimental methods used in the following examples are generally conventional, unless otherwise specified, and the materials, reagents, etc. used in the following examples are commercially available, unless otherwise specified.

[0057] Example 1

[0058] 1.1 Materials

[0059] DMEM / F12 (1:1) basic (1x) (gibco, 6123073), high glucose DMEM (Servicebio, G4515), fetal bovine serum (Punosai, 164210-50), penicillin-streptomycin mixture (double antibody, 100x) (Servicebio, G4003-100ML), ITS-G medium supplement (100x) (Servicebio, G4028-10ML), BeyoRT™ II cDNA first strand synthesis kit (RNase H-) (Biyuntian, D7168M), Anti-Cardiac Troponin T Rabbit pAb (anti-cardiac troponin T rabbit polyclonal antibody) (Servicebio, GB113806-100), non-essential amino acids (Servicebio, G4219), DAPI staining reagent (Servicebio, G1012), α-actinin 4 Recombinant Rabbit Monoclonal Antibody (α-actinin 4 recombinant rabbit monoclonal antibodies, Hangzhou Huaan Biotechnology Co., Ltd., JU20-23), primers were synthesized by Shanghai Shenggong Biotechnology, RepSox (2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine, GLPBIO, GC16793), Forskolin (GLPBIO, GC11920), Psoralen (Beijing BetterKang Biotechnology Co., Ltd., 23010802).

[0060] 1.2 Methods

[0061] 1.2.1 Extraction and primary culture of MEFs (mouse embryonic fibroblasts)

[0062] C57BL / 6 pregnant mice at 13.5 days of gestation were killed by cervical dislocation and then immersed in 75% ethanol for 5 minutes. The skin of the lower abdomen was cut open with scissors and forceps, and the skin was pulled to both sides to fix it. After exposing and separating the uterus, the uterus was transferred to a sterile dish and washed 2-3 times. The uterus was opened, the fetal membranes were removed, the fetuses were taken out and counted, and the fetuses were transferred to a culture dish containing PBS. The head, limbs and internal organs of the fetus were removed, and the trunk was retained. It was washed 2-3 times with PBS until it was bloodless. The clean mouse embryo trunk was transferred to a small dish and cut into about 1mm 3The following fragments were mixed with PBS, centrifuged at 800rpm for 1min to remove the supernatant, and complete culture medium (DMEM / F12+10% fetal bovine serum+1x penicillin-streptomycin mixture) was added to the precipitate and inoculated into a T25 culture flask. The first medium change was performed after 24h, and then the medium was changed every 2 days. When fibroblasts crawled out of the tissue block to 50%, the tissue block was gradually removed, and the fibroblasts were passaged when they grew and merged to 90%. P3 was used for the experiment.

[0063] 1.2.2 Observation of cell morphology using an inverted microscope

[0064] MEFs at passage P3 were cultured at a rate of 1×10 5 Cells were plated in 12-well plates at 100 μg / well. When the cells grew to about 80%, the culture medium was replaced with myocardial induction medium (CM) (high glucose DMEM + 10% v / v fetal bovine serum + 1% v / v penicillin-streptomycin + 50 mg / L L-ascorbic acid-2-trisodium phosphate + 0.1 mM β-mercaptoethanol + 1x ITS-G culture medium supplement + 1× non-essential amino acids). The cells were divided into CM group (culture medium was myocardial induction medium), RF group (culture medium was myocardial induction medium plus RF), and PRF group (culture medium was myocardial induction medium plus PRF), where R was RepSox, F was Forskolin, and P was psoralen; RF was RepSox+Forskolin, and PRF was psoralen+RepSox+Forskolin; the concentrations of R, F, and P were 5 µmol / L, 10 µmol / L, and 10 µmol / L, respectively. Each group had 6 wells and was cultured for 8h-6d. Cell morphology was observed under an inverted microscope.

[0065] 1.2.3 Real-time fluorescence quantitative PCR detection of myocardial related gene expression

[0066] Cell culture and grouping refer to 1.2.2. Three parallel wells were set up in each group. The medium was changed every 2 days. The cells induced for 4 days were collected, and total RNA was extracted using TRIzol. 500 ng of total RNA was synthesized into first-strand cDNA using the Bio-rad CFX Opus 96 real-time fluorescence quantitative PCR instrument. The qPCR reaction was performed using the following conditions: 95 ℃ pre-denaturation for 30 s; 95 ℃ 10 s, 56 ℃ 30 s, 72 ℃ 30 s, 40 cycles; the melting curve reaction conditions were 95 ℃ 15 s, 60 ℃ 60 s, 95 ℃ 15 s. The primer sequences are shown in Table 2. GAPDH was used as the internal reference. The comparative cycle threshold (CT) method was used. The results were analyzed by 2 -ΔΔCTMethods The relative expression levels of Myh6, β-MHC, TNNT2, and RyR2 mRNA were calculated. The specific primer designs are shown in Table 1.

[0067] Table 1

[0068]

[0069] 1.2.4 Immunofluorescence detection of the expression levels of typical cardiomyocyte markers CTNT and α-actinin during psoralen induction

[0070] The P3 generation MEFs were plated in a 6-well plate at 80,000 cells / well to prepare cell slides. The groups were grouped as described in 1.2.2. The cells were immunofluorescently stained at 2 days, washed 3 times with PBS, and fixed in 4% paraformaldehyde fixative for 30 minutes. The cells were washed with PBS 3 times, each for 5 minutes. The cells were permeabilized with permeabilization solution for 10 minutes, and after washing, they were blocked in 5% BSA solution at room temperature for 30 minutes. Primary antibodies CTNT (1:75) and α-actinin (1:75) were added and incubated at 4°C overnight. After washing, secondary antibodies were added and incubated at 37°C for 1 hour. The nuclei were stained with DAPI, washed, sealed, and observed under a fluorescence microscope.

[0071] 1.3 Statistical methods

[0072] SPSS 26.0 software was used for statistical analysis. Data were expressed as mean ± standard deviation (x¯±s). One-way analysis of variance was used for comparison among groups. LSD test was used for multiple comparisons when variances were equal, and Tambane's T2 test was used when variances were unequal. p The difference was statistically significant when the value was <0.05.

[0073] 1.4 Results and Analysis

[0074] 1.4.1 Changes in MEF cell morphology after PRF culture

[0075] Microscopic observation showed that the MEFs-P3 (referring to the P3 generation of MEFs) cells were spindle-shaped, with large cell bodies, and a small number of polygonal cells with protrusions of different lengths. The nuclei were large and oval or round. The morphology of the CM group was no different from that of MEFs-P3 (see Figure 1 A in Figure 1 In the RF group, most cells became smaller and elongated, with occasional strip-shaped cells with strong refractive index (see Figure 1 C in the figure). Most cells in the PRF group were long and plump, with strong refractive index and spontaneous beating (see Figure 1 Middle D).

[0076] 1.4.2 Comparison of MYH6, TNNT2, RyR2, and β-MHC mRNA expression levels in each group after 4 days of culture

[0077] After 4 days of culture, the mRNA expressions of TNNT2, β-MHC, and RyR2 in the RF group increased significantly compared with those in the CM group ( p <0.001, p <0.01, p <0.001), there was no significant difference in MYH6 mRNA expression level; compared with the RF group, the expressions of MYH6, TNNT2, RyR2, and β-MHC mRNA in the PRF group were significantly increased ( p <0.001). The results are shown in Table 2. Figure 2 .

[0078] Table 2

[0079]

[0080] 1.4.3 Immunofluorescence detection of CTNT and α-actinin expression levels in each group after 2 days of culture

[0081] After 2 days of culture, the results of immunofluorescence showed that the expression of CTNT and α-actinin in the RF group was significantly increased compared with that in the CM group ( p <0.001, p <0.05); compared with the RF group, the expressions of CTNT and α-actinin in the PRF group were significantly increased ( p <0.001), see Figure 3-Figure 6 .

[0082] Example 2

[0083] Embodiment 2 and embodiment 3 are set with reference to embodiment 1. The difference between embodiment 2 and embodiment 1 is that:

[0084] The cells were divided into CM group (culture medium was myocardial induction culture medium), RF group (culture medium was myocardial induction culture medium plus RF), and PRF group (culture medium was myocardial induction culture medium plus PRF). The concentration range of R was 10µmol / L, the concentration range of F was 10µmol / L, and the concentration range of P was 1µmol / L. The expression of myocardial-related genes was detected by real-time fluorescence quantitative PCR as described in 1.2.3.

[0085] The results are shown in Table 3. Figure 7 :

[0086] Table 3

[0087]

[0088] The results of PCR experiments after 4 days of culture are shown in Table 3. Figure 7 As shown, compared with the CM group, the mRNA expressions of MYH6, TNNT2, β-MHC, and RyR2 in the RF group were significantly increased ( p <0.01, p <0.001, p <0.001, p <0.001); compared with the RF group, the mRNA expressions of MYH6, TNNT2, β-MHC, and RyR2 in the PRF group were significantly increased ( p <0.001).

[0089] The above results suggest that R concentration of 10µmol / L, F concentration of 10µmol / L, and P concentration of 1µmol / L can induce embryonic fibroblasts to reprogram into cardiomyocyte-like cells.

[0090] Example 3

[0091] Embodiment 3 is set with reference to embodiment 1. The difference between embodiment 3 and embodiment 1 is that:

[0092] The cells were divided into CM group (culture medium was myocardial induction culture medium), RF group (culture medium was myocardial induction culture medium plus RF), and PRF group (culture medium was myocardial induction culture medium plus PRF). The concentration range of R was 1µmol / L, the concentration range of F was 1µmol / L, and the concentration range of P was 100µmol / L. The expression of myocardial-related genes was detected by real-time fluorescence quantitative PCR as described in 1.2.3.

[0093] The results are shown in Table 4. Figure 8 :

[0094] Table 4

[0095]

[0096] The results of PCR experiments after 4 days of culture are shown in Table 4. Figure 8 As shown in the figure, compared with the CM group, there was no significant difference in the mRNA expression levels of TNNT2, MYH6, β-MHC, and RyR2 in the RF group; compared with the RF group, the mRNA expressions of MYH6, TNNT2, β-MHC, and RyR2 in the PRF group were significantly increased ( p <0.001).

[0097] The above results suggest that R concentration of 1µmol / L, F concentration of 1µmol / L, and P concentration of 100µmol / L can induce embryonic fibroblasts to reprogram into cardiomyocytes, and the effect of PRF is better than that of RF.

[0098] Comparative Example

[0099] A comparative example was set up with reference to Example 1, and the expression of myocardial related genes TNNT2 and RyR2 was detected by real-time fluorescence quantitative PCR. The setting and results of the comparative example are shown in Table 5.

[0100] Table 5

[0101]

[0102] The results are shown in Table 6. Fig. 9 :

[0103] Table 6

[0104]

[0105] The sources of the reagents in the comparative example are as follows:

[0106] SD208 (GLPBIO, GC13904)

[0107] Isopsoralen (Beijing BetterKang Biopharmaceutical Technology Co., Ltd., 23032704)

[0108] From Table 6, Fig. 9 It can be seen that after 4 days of induction, compared with the CM group, the mRNA expressions of TNNT2 and RyR2 in the PRF group of Example 1, Comparative Example 1 and Comparative Example 2 were significantly increased ( p <0.001); the mRNA expression levels of TNNT2 and RyR2 in the PRF group of Example 1 were significantly increased compared with those in Comparative Example 1 and Comparative Example 2 ( p <0.001). According to this result, when RepSox in the PRF combination is replaced by other TGF-β inhibitors of equal concentration, and psoralen is replaced by isopsoralen of equal concentration, it also has the effect of inducing embryonic fibroblasts to directly reprogram into cardiomyocytes. And at the same concentration, RepSox is better than SD208 in inducing embryonic fibroblasts to directly reprogram into cardiomyocytes, and psoralen is better than isopsoralen in inducing embryonic fibroblasts to directly reprogram into cardiomyocytes.

Claims

1. A culture medium for inducing the preparation of cardiomyocytes, It is characterized in that The culture medium comprises a composition and a myocardial induction culture medium; the composition consists of psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin; the concentrations of psoralen, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine and forskolin are 1µmol / L-100µmol / L, 1µmol / L-10µmol / L and 1µmol / L-10µmol / L respectively.

2. The culture medium according to claim 1, It is characterized in that The culture medium further comprises at least one of fetal bovine serum, penicillin-streptomycin, L-ascorbic acid-2-trisodium phosphate, β-mercaptoethanol, ITS or non-essential amino acids.

3. A method for inducing the preparation of cardiomyocyte-like cells, It is characterized in that The method comprises the following steps: contacting embryonic fibroblasts with the culture medium according to claim 1, inducing cell reprogramming of the embryonic fibroblasts, and generating cardiomyocyte-like cells.

4. The method according to claim 3, It is characterized in that The embryonic fibroblasts are derived from mouse embryos.

5. The method according to claim 3 or 4, It is characterized in that The embryonic fibroblasts are derived from 10-15 day old mouse embryos.

6. Use of the culture medium according to any one of claims 1 to 2 or the method according to any one of claims 3 to 5 in preparing cardiomyocytes.

7. A kit, It is characterized in that The kit comprises the culture medium according to any one of claims 1 to 2.